Moshkevich Solomon

Moshkevich Solomon, president of clinical diagnostics at Natera (NTRA), has filed 99 Form 4 transactions, all in the single company. The pattern is one-sided. His total sell value across all filings is $26,459,477.95, with zero buy value and zero acquired value. In the recent window, he has executed 24 open-market sales and no purchases. The recent trades cluster around the first of each month. On September 2, 2026, he sold shares worth $4,955,713.04, the largest single transaction in the recent set. The surrounding days show smaller sales: $193,144.02 and $449,291.50 on September 1, and $319,758.20 the same day. August 3 brought seven separate sales totaling roughly $905,626.90, with individual values from $34,393.14 to $330,181.25. July 1 had three sales worth $709,774, $82,218, and $26,718.50. June 1 had four sales totaling $655,294.81. The most recent filing, dated October 1, 2026, shows three sales worth $766,217.56, $394,103.70, and $82,324. A gift of zero value appears on September 16, 2026. No option exercises, grants, or tax-withholding codes appear in the recent trades. The sales are open-market dispositions, and the absence of any purchase code P in the entire filing history means Solomon has not bought NTRA shares on the open market in any reported period. The direction is consistently toward reducing his position, with the largest dollar amounts concentrated in the late summer and early fall of 2026.